Next Test News Today

Hillsdale Investment Management Inc. lessened its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 6.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 136,380 shares of the company’s stock after selling 9,720 shares during the quarter. Hillsdale Investment […]

Guardant Health (NASDAQ:GH – Get Free Report) will announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.72) per share for the quarter. Guardant Health has set its FY 2024 guidance at EPS.Parties that are interested in registering for the company’s conference call can […]

Mach 1 Financial Group LLC cut its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 15.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,160 shares of the company’s stock after selling 2,916 shares during the quarter. Mach 1 Financial […]

Guardant Health (NASDAQ:GH – Get Free Report) had its price objective dropped by research analysts at Canaccord Genuity Group from $45.00 to $30.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside […]

Guardant Health (NASDAQ:GH – Get Free Report) had its price target lowered by stock analysts at Canaccord Genuity Group from $45.00 to $30.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would indicate a potential upside of 64.93% from […]

Craig Hallum initiated coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $28.00 target price on the stock. GH has been the subject of several other reports. Canaccord Genuity Group cut their price objective […]

Craig Hallum assumed coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $28.00 price objective on the stock. A number of other research analysts have also weighed in on the company. Guggenheim reissued a […]

Craig Hallum began coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report sent to investors on Wednesday, Marketbeat.com reports. The firm issued a buy rating and a $28.00 price target on the stock. Several other brokerages have also issued reports on GH. The Goldman Sachs Group decreased their target price […]

Guardant Health (NASDAQ:GH – Free Report) had its target price cut by The Goldman Sachs Group from $32.00 to $28.00 in a research report released on Monday morning, Benzinga reports. They currently have a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. JPMorgan Chase & Co. […]

Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Guggenheim in a research report issued on Friday, Benzinga reports. Several other equities research analysts have also recently issued reports on the stock. Wolfe Research initiated coverage on shares of Guardant Health in a research report on Wednesday, […]